Hematin μ-oxo dimer ([Fe(III)PPIX]2O)

The hematin μ-oxo dimer is a critical intermediate in the detoxification pathway of the malaria parasite, Plasmodium falciparum, located within its acidic food vacuole (Egan, 2008, J. Inorg. Biochem.) [1]. During the intraerythrocytic stage, the parasite digests host hemoglobin to obtain essential amino acids, releasing free heme (ferriprotoporphyrin IX) as a byproduct (Hempelmann, 2007, Parasitol. Res.) [2]. This free heme is highly toxic to the parasite because it can generate reactive oxygen species and disrupt cellular membranes (Sullivan, 2002, Int. J. Parasitol.) [3]. To mitigate this toxicity, the parasite sequesters the heme into an insoluble, non-toxic crystalline polymer known as hemozoin, or malaria pigment (Wikipedia, 'Hemozoin') [4]. The μ-oxo dimer is a soluble, dimeric form of ferriprotoporphyrin IX that exists in the acidic environment of the food vacuole and serves as a precursor or transient state during hemozoin formation [1, 2]. This molecule is the primary therapeutic target for quinoline-based antimalarial drugs, such as chloroquine and quinine [1]. These drugs bind specifically to the hematin μ-oxo dimer, preventing its incorporation into the growing hemozoin crystal [2]. The resulting accumulation of soluble drug-heme complexes is lethal to the parasite, leading to the breakdown of the digestive vacuole and cell lysis [3]. Understanding the interaction between drugs and this dimer is vital for addressing widespread resistance caused by mutations in parasite transport proteins [3, 4].

Other names

Ferriprotoporphyrin IX μ-oxo dimerHeme dimerμ-oxo-bis(protoporphyrin IX iron(III))Malaria pigment precursor

Quinoline antimalarials bind to the hematin μ-oxo dimer in the acidic food vacuole, preventing its sequestration into hemozoin crystals and forming toxic complexes that cause parasite death (Egan, 2008; Hempelmann, 2007).